May 7, 2026 — A Kirkland pharmacy was sanctioned for dangerous compounding practices. Its ... compound GLP-1 medications or any other product that required sterile drug ...Read more
Friday, May 15, 2026
Former Pharmacy President Sentenced to 24 Months in Prison for Health Care Fraud and Kickback Scheme Involving Compounded Medications
$33 Million Restitution and $27 Million Forfeiture Ordered Under Sentence**
NEWARK, N.J. – On April 1, 2026 Adam Brosius, 61, of Delray Beach, Florida, was sentenced to 24 months in prison for his role in a $33 million health care fraud and kickback scheme, U.S. Attorney Robert Frazer announced.
According to documents filed in this case and statements made in court:
From 2014 through 2016, Brosius and others used Main Avenue Pharmacy, a mail-order pharmacy with a storefront in Clifton, New Jersey, to run an illegal kickback scheme involving medically unnecessary compounded drugs including scar creams, pain creams, migraine mediation, and vitamins. Brosius worked as Main Avenue’s director of business development, and later as its president.
As part of the scheme, Main Avenue identified compounded drugs that would yield exorbitant reimbursements from health insurers, including both federal and commercial payers. Once Main Avenue identified lucrative formulas, it would create large prescription pads with those formulas on it and distribute the pads to marketers across the country. The marketing companies would in turn distribute the prescription pad to telemedicine companies and doctors with whom they had a financial arrangement.
After filling prescriptions, Main Avenue submitted claims to health care benefit programs for reimbursement, including Medicare, Tricare, and commercial payers in New Jersey and elsewhere. After Main Avenue obtained reimbursement, it paid kickbacks to marketers who had generated the prescriptions. Main Avenue signed contracts with many of the marketers, which detailed the illicit kickback arrangement, which called for Main Avenue to pay each marketer money based on the volume of referrals of compounded prescriptions and the reimbursement amount that Main Avenue received. Main Avenue received approximately $33 million in reimbursements for compounded medications alone from health care benefit programs. Over $5.8 million of that amount was paid by TRICARE, a federal payer.
In addition to the prison term, Judge Madeline Cox Arleo also ordered $33 million in restitution, $27 million in forfeiture, and a term of supervised release.
U.S. Attorney Frazer credited the following law enforcement organizations with the investigation leading to the sentencing: the Federal Bureau of Investigation, under the direction of Special Agent in Charge Stefanie Roddy; the U.S. Department of Health and Human Services Office of Inspector General, under the direction of Special Agent in Charge Naomi Gruchacz; and U.S. Department of Defense, Office of Inspector General, Defense Criminal Investigative Service, Northeast Field Office, under the direction of Special Agent in Charge Christopher M. Silvestro.
The government is represented by Assistant U.S. Attorneys Katherine M. Romano and Matthew Specht.
The Department of Justice has established the National Fraud Enforcement Division. The core mission of the National Fraud Enforcement Division is to zealously investigate and prosecute those who steal or fraudulently misuse taxpayer dollars. The National Fraud Enforcement Division will fulfill that mission by coordinating with agencies responsible for administering benefit programs; partnering with federal, tribal, state, territorial, and local law enforcement on fraud-fighting efforts; developing systems and processes that ensure efficient identification of fraud against taxpayer dollars; and equipping prosecutors and law enforcement with state-of-the-art tools and resources needed to bring criminal actors to justice. The attorneys in the National Fraud Enforcement Division will work every day to protect the financial integrity of our government and the tax system that supports it.
###
Defense counsel:
David A. Eskew, Esq., New York, New York.
Mark A. Berman, Esq., Hackensack, New Jersey.
Updated April 20, 2026
CMS Has Limited Oversight of Selected Compounded Drugs Prescribed to Medicare Part D Enrollees: Proposes Changes
Issued on | Posted on | Report number: A-05-21-00008
Subscribe to:
Posts (Atom)